20/20 Biolabs, Inc.
AIDX
$0.53
$0.012.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -79.13% | -184.44% | -4.71% | 55.94% | 30.76% |
| Total Depreciation and Amortization | -6.16% | -23.83% | -38.34% | -39.54% | -40.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 251.88% | 444.91% | -40.45% | -85.71% | -59.22% |
| Change in Net Operating Assets | -1.08% | -155.12% | 2,293.16% | -24.30% | 28.27% |
| Cash from Operations | -13.37% | -163.98% | 4.62% | 33.77% | 27.82% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 257.14% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 2,500.10% | -100.00% | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 1,610.79% | 257.09% | 535.63% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.22% | 1,512.88% | 72.12% | 124.05% | 22.39% |